LUNAC Therapeutics
LUNAC Therapeutics develops advanced anticoagulants targeting activated Factor XII.
Filter & sort
Recently funded companies in the UK tech ecosystem.
Startups
222
Total raised
£4.1B
across 308 rounds
LUNAC Therapeutics develops advanced anticoagulants targeting activated Factor XII.
Lab Thread builds software for laboratory data management.
Developing targeted non-antibiotic treatments for bacterial infections.

Latent Labs builds AI foundation models to make biology programmable.
Laverock Therapeutics develops a gene silencing platform for programmable advanced therapies.

Lightcast Discovery builds a novel single-cell functional analysis platform for life science research.
Lindus Health operates a technology platform to run faster end-to-end clinical trials.
MGB Biopharma develops a novel class of anti-infectives to tackle antibiotic resistance.